The infection efficiency of BMDMs was determined by detecting the percentages of GFP+ cells (Figure S6C, Supporting Information) or measuring the mRNA levels of EBI2 by quantitative PCR (Figure S6D, Supporting Information). The gene discussed is GPR183; the disease is infection.